12 Participants Needed

Brain-Controlled Spinal Stimulation for Spinal Cord Injury

MM
DC
CT
Overseen ByChristina Thruston, DPT
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).

Do I need to stop taking my current medications for the trial?

The trial protocol does not specify if you need to stop taking your current medications, but it excludes individuals on investigational drugs or any intervention that could affect neuromotor function.

What data supports the effectiveness of the treatment BCI-TSCS for spinal cord injury?

Research shows that transcutaneous spinal cord stimulation (tSCS), a component of BCI-TSCS, can help improve motor function in people with spinal cord injuries by stimulating the spinal cord non-invasively. Studies have found that tSCS can enhance sensorimotor recovery and facilitate motor responses, suggesting its potential effectiveness in rehabilitation.12345

Is Brain-Controlled Spinal Stimulation generally safe for humans?

Transcutaneous spinal cord stimulation (tSCS), a component of the treatment, is non-invasive and has been studied in people with spinal cord injuries, showing it can stimulate spinal circuits without major safety concerns. However, more specific safety data for the combined use with brain-computer interfaces is limited.16789

How is the treatment BCI-TSCS different from other treatments for spinal cord injury?

BCI-TSCS is unique because it combines brain-computer interface technology with transcutaneous spinal cord stimulation, allowing for non-invasive stimulation of the spinal cord to enhance motor function. This approach is novel as it potentially enables the brain to directly influence spinal cord activity, which is different from traditional methods that do not integrate brain signals.1231011

Research Team

MM

Matija Milosevic, PhD

Principal Investigator

University of Miami - MSOM

Eligibility Criteria

This trial is for adults aged 21-70 with an incomplete spinal cord injury at or above T10 level, who are more than 6 months post-injury. Participants must have some detectable motor function in their legs and be able to walk at least 10 meters with assistance. They should commit to a 6-month training program and not have metal implants affected by magnetic stimulation, severe spasticity, skin breakdown where electrodes attach, recent seizures, major cognitive issues, or substance disorders.

Inclusion Criteria

I can commit to a 6-month intensive training and assessment program.
I have muscle movement in at least 2 muscles on each side of my body, confirmed by a muscle test.
I have a spinal cord injury above T10 and it's been over 6 months since the injury.
See 2 more

Exclusion Criteria

Individuals with metal implants in their head and other implantable devices in the body that could be affected by TMS or TSCS
I don't have conditions that prevent me from having TMS or TSCS.
I have a urinary tract infection, unhealed fracture, contracture, or pressure sore.
See 12 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS) therapy

up to 12 months

Follow-up

Participants are monitored for safety and effectiveness after treatment

4-8 weeks

Treatment Details

Interventions

  • BCI-TSCS
Trial Overview The study tests Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS) therapy aimed at improving walking ability in people with incomplete SCI. It involves intensive training sessions over six months using BCI-TSCS technology to stimulate the spinal cord and potentially enhance mobility.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS)Experimental Treatment1 Intervention
Subjects will participate in the therapy for up to 12 months

BCI-TSCS is already approved in United States, Switzerland for the following indications:

πŸ‡ΊπŸ‡Έ
Approved in United States as BCI-TSCS for:
  • Improving walking in individuals with incomplete spinal cord injury (SCI)
πŸ‡¨πŸ‡­
Approved in Switzerland as BCI-TSCS for:
  • Rehabilitation of walking in individuals with incomplete spinal cord injury (SCI)

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

United States Department of Defense

Collaborator

Trials
940
Recruited
339,000+

Findings from Research

Transcutaneous spinal cord stimulation (tSCS) shows potential for generating motor activity in individuals with spinal cord injury, but the overall quality of the studies reviewed was poor-to-fair, indicating a need for more rigorous research.
The review identified significant variability in stimulation parameters and outcome measurements across the 25 studies analyzed, highlighting the necessity for standardized methods to improve the reliability and comparability of tSCS research.
Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review.Taylor, C., McHugh, C., Mockler, D., et al.[2022]
Cervical transcutaneous spinal cord stimulation (tSCS) can effectively activate sensory fibers at lower stimulation intensities when the cathode electrode is positioned at the C7 or T1 vertebra, compared to C6, which may enhance rehabilitation outcomes for upper-limb motor recovery after spinal cord injury.
Using smaller electrode sizes not only lowers the activation threshold for sensory fibers but also optimizes the recruitment of these fibers before Ξ±-motor fibers, suggesting a strategic approach to improve hand muscle activation during tSCS therapy.
Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis.de Freitas, RM., Capogrosso, M., Nomura, T., et al.[2022]
Transcutaneous spinal cord stimulation (tSCS) can non-invasively enhance sensorimotor rehabilitation by modulating spinal cord circuitry, showing promise for improving recovery after spinal cord injuries.
Single-site tSCS can influence excitability across multiple spinal cord segments, while multi-site tSCS can enhance spinal reflexes and corticospinal networks, indicating its potential for more effective rehabilitation strategies.
Neural Substrates of Transcutaneous Spinal Cord Stimulation: Neuromodulation across Multiple Segments of the Spinal Cord.Barss, TS., Parhizi, B., Porter, J., et al.[2022]

References

Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review. [2022]
Optimizing sensory fiber activation during cervical transcutaneous spinal stimulation using different electrode configurations: A computational analysis. [2022]
Neural Substrates of Transcutaneous Spinal Cord Stimulation: Neuromodulation across Multiple Segments of the Spinal Cord. [2022]
Contralateral Selectivity of Upper-Limb Motor Pools via Targeted Stimulation of the Cervical Spinal Cord. [2023]
Transcutaneous Electrical Spinal Cord Stimulation to Promote Recovery in Chronic Spinal Cord Injury. [2022]
Effects of transcutaneous spinal stimulation on spatiotemporal cortical activation patterns: a proof-of-concept EEG study. [2022]
Microdermabrasion facilitates direct current stimulation by lowering skin resistance. [2023]
Spinal direct current stimulation with locomotor training in chronic spinal cord injury. [2021]
The effect of transcutaneous spinal direct current stimulation on corticospinal excitability in chronic incomplete spinal cord injury. [2018]
Transcranial magnetic stimulation-based closed-loop modality for activity of daily living gain in spinal cord injury: a retrospective study using propensity score matching analysis. [2023]
11.United Statespubmed.ncbi.nlm.nih.gov
Transcutaneous Spinal Cord Stimulation and Motor Rehabilitation in Spinal Cord Injury: A Systematic Review. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security